The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
June 13th 2025
Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.
Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.
Measuring Cortisol Levels in Hair Shows Link Between Stress, Obesity
Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin
Tailoring Diabetes Coaching to Patients Trims Hospital Visits
Comparing Surgery, Medication for Type 2 Diabetes in Overweight Patients